Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
Drug Binding to Blood Components01:30

Drug Binding to Blood Components

When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Assessment of hazards of an electromagnetic field generated by the monitor (a study of conditions of short-term work of a personal computer operator)].

Radiatsionnaia biologiia, radioecologiia·1996
Same author

[Changes in the content of substance P, beta-endorphin and corticosterone in the hypothalamus and blood of rats with emotional stress after the administration of the delta sleep-inducing peptide].

Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova·1995
Same author

[Cascade aftereffects of administering delta-sleep inducing peptide].

Biulleten' eksperimental'noi biologii i meditsiny·1995
Same author

[Evaluation of changes in electrophysiological and hormonal parameters in rabbits resulting from short-term low-intensity ultra-high-frequency irradiation].

Radiatsionnaia biologiia, radioecologiia·1995
Same author

[The microcirculatory function and immune status indices of patients with rheumatic heart defects combined with pulmonary hypertension].

Likars'ka sprava·1994
Same author

[An androgenic program of expression of the particular estrogen-binding protein is present in male rats in all hepatocytes].

Ontogenez·1993

Related Experiment Video

Updated: Jun 29, 2026

Biochemical Reconstitution of Steroid Receptor•Hsp90 Protein Complexes and Reactivation of Ligand Binding
11:07

Biochemical Reconstitution of Steroid Receptor•Hsp90 Protein Complexes and Reactivation of Ligand Binding

Published on: September 21, 2011

[Rabbit testosterone-binding globulin and its use in concurrent protein-binding analysis].

Iu V Polyntsev, A G Volchek, V B Rozen

    Problemy Endokrinologii
    |November 1, 1977
    PubMed
    Summary

    This study identifies a specific protein in rabbits that binds to testosterone and evaluates its potential for measuring hormone levels in blood samples. Researchers found that this protein, known as testosterone-binding globulin, maintains consistent binding levels across different stages of rabbit development. Because this protein specifically binds to testosterone and related androgens, it serves as a reliable tool for laboratory tests that measure these hormones in humans and animals. The findings suggest that this rabbit-derived protein is a practical and effective component for standard competitive protein-binding assays.

    Keywords:
    steroid hormone quantificationandrogen binding affinitybiochemical assay validationmammalian plasma proteins

    Frequently Asked Questions

    More Related Videos

    Determining Binding Affinity (KD) of Radiolabeled Antibodies to Immobilized Antigens
    07:39

    Determining Binding Affinity (KD) of Radiolabeled Antibodies to Immobilized Antigens

    Published on: June 23, 2022

    An Optimized Quantitative Pull-Down Analysis of RNA-Binding Proteins Using Short Biotinylated RNA
    07:55

    An Optimized Quantitative Pull-Down Analysis of RNA-Binding Proteins Using Short Biotinylated RNA

    Published on: February 17, 2023

    Related Experiment Videos

    Last Updated: Jun 29, 2026

    Biochemical Reconstitution of Steroid Receptor•Hsp90 Protein Complexes and Reactivation of Ligand Binding
    11:07

    Biochemical Reconstitution of Steroid Receptor•Hsp90 Protein Complexes and Reactivation of Ligand Binding

    Published on: September 21, 2011

    Determining Binding Affinity (KD) of Radiolabeled Antibodies to Immobilized Antigens
    07:39

    Determining Binding Affinity (KD) of Radiolabeled Antibodies to Immobilized Antigens

    Published on: June 23, 2022

    An Optimized Quantitative Pull-Down Analysis of RNA-Binding Proteins Using Short Biotinylated RNA
    07:55

    An Optimized Quantitative Pull-Down Analysis of RNA-Binding Proteins Using Short Biotinylated RNA

    Published on: February 17, 2023

    Area of Science:

    • Endocrinology and reproductive biology research involving testosterone-binding globulin
    • Biochemical assays and protein-binding analysis techniques

    Background:

    No prior work had resolved the full utility of rabbit-derived proteins for hormone quantification assays. It was already known that specific globulins facilitate steroid transport within the circulatory system. That uncertainty drove researchers to investigate whether rabbit-derived proteins could serve as reliable reagents. Prior research has shown that binding affinities vary significantly between different mammalian species. This gap motivated a detailed characterization of the protein's physical and chemical properties. Scientists sought to determine if these proteins remained stable across various developmental stages. Previous studies lacked a comprehensive assessment of binding specificity for common steroid hormones. This study addresses these limitations by isolating and testing the protein's performance in standardized laboratory environments.

    Purpose Of The Study:

    The aim of this study is to characterize rabbit-derived testosterone-binding globulin and evaluate its utility in competitive protein-binding assays. Researchers sought to determine if this protein possesses the necessary biochemical stability for laboratory applications. The investigation addresses the need for reliable reagents in the quantification of circulating androgens. Scientists aimed to verify whether the protein's binding properties remain consistent across different developmental stages. The team also intended to assess the specificity of the protein by testing its interaction with various non-androgenic steroids. This work was motivated by the requirement for standardized methods in hormone analysis across human and animal models. By examining the affinity for dehydrotestosterone, the study provides a clearer understanding of the protein's functional range. The researchers ultimately intended to establish a protocol for the widespread practical use of this globulin in clinical and research diagnostics.

    Main Methods:

    Review approach involved isolating the protein from various rabbit cohorts to assess its biochemical profile. Investigators utilized sedimentation analysis to determine the physical characteristics of the purified globulin. The team performed competitive binding assays to evaluate the protein's interaction with diverse steroid hormones. Researchers compared the binding affinity of testosterone against estradiol, progesterone, and cortisol. They also examined the relative binding strength of dehydrotestosterone to confirm specificity. The study design included plasma samples from human subjects and multiple rabbit developmental groups. Scientists validated the assay performance by comparing their findings with previously published data from other laboratories. This systematic evaluation ensured the reliability of the protein for consistent hormone quantification across different species.

    Main Results:

    Key findings from the literature demonstrate that the protein maintains a consistent binding capacity across all examined rabbit developmental stages. The association constant for the protein is established at the 10(8) M-1 order. Sedimentation analysis confirms a characteristic coefficient of 4S for the isolated globulin. The researchers observed that estradiol, estron, progesterone, and cortizol show no measurable affinity for this protein. Dehydrotestosterone exhibits an affinity approximately three times greater than that of testosterone. The competitive binding assays yielded results that align with those reported by other investigators. This consistency was observed across plasma samples derived from men, women, and both male and female rabbits. The data support the conclusion that the protein is highly effective for quantifying androgens in various biological fluids.

    Conclusions:

    The authors propose that this rabbit protein serves as a robust reagent for competitive binding assays. Synthesis and implications suggest that consistent binding capacity across developmental stages supports its broad application. Researchers indicate that the high affinity for specific androgens makes it suitable for clinical hormone measurements. The study confirms that results obtained using this method align with established literature findings. Authors suggest that the lack of cross-reactivity with other steroids enhances its diagnostic precision. This work provides a validated protocol for implementing the protein in routine laboratory workflows. The team concludes that the protein's stability facilitates reliable quantification in diverse plasma samples. These findings support the adoption of this specific globulin for widespread practical use in endocrinology.

    The protein exhibits a high association constant of 10(8) M-1 and a sedimentation coefficient of 4S. Researchers propose these characteristics allow it to function effectively in competitive binding assays for testosterone and related androgens.

    The researchers utilized competitive protein-binding analysis to evaluate the protein's utility. This technique relies on the protein's ability to bind specific hormones, allowing for the quantification of androgen levels in blood plasma samples from humans and rabbits.

    The researchers state that dehydrotestosterone exhibits an affinity approximately three times greater than that of testosterone. This specific binding preference is necessary for the protein to distinguish between different androgenic compounds during laboratory testing.

    The authors used plasma samples from mature males, females, pregnant rabbits, and fetuses. This data type allowed the team to demonstrate that binding capacity remains consistent across various ontogenetic groups, ensuring the protein's reliability as a reagent.

    The researchers measured the binding capacity of the globulin across different life stages. They observed that the protein levels were remarkably similar between the rabbit mother and the fetus, indicating stable expression throughout development.

    The authors propose that the protein's performance in human and rabbit plasma samples validates its practical utility. They suggest that because these results coincide with other published data, the protein is ready for widespread implementation in clinical and research settings.